Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: A Collaborative Transplant Study Report
Open Access
- 12 March 2019
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (10) , 2805-2813
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantationPharmacogenetics and Genomics, 2017
- Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody DevelopmentTransplantation, 2016
- Meltdose Tacrolimus PharmacokineticsTransplantation Proceedings, 2016
- Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen TestingTransplantation, 2015
- Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical managementTransplantation Reviews, 2015
- Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantationKidney International, 2014
- Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failureKidney International, 2014
- The collaborative transplant study registryTransplantation Reviews, 2013
- Impact of Tacrolimus Intraindividual Variability and CYP3A5 Genetic Polymorphism on Acute Rejection in Kidney TransplantationTherapeutic Drug Monitoring, 2012
- High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantationNephrology Dialysis Transplantation, 2010